Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 59 min ago
PreprintCC BY-NDmedRxiv

Pandemic-Driven Shifts in RSV Diversity, Evolution, and Global Spread

1 more authors
  1. 1Department of Pediatric Infectious Diseases and Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

Abstract

The COVID-19 pandemic dramatically disrupted the seasonal circulation of RSV, with subsequent heterogeneous global resurgence. We aimed to characterize how pandemic-era disruptions restructured global RSV transmission dynamics, evolutionary patterns, and drivers of reemergence. We show that RSV-A and RSV-B genetic diversity underwent profound pandemic-associated suppression followed by heterogeneous resurgence. The post-pandemic period was characterized by pronounced changes in diversity, with the emergence of novel RSV-A genotypes (A.D.3 and A.D.5.2) and the expansion of the RSV-B, B.D.E.1 genotype. The recovery of RSV-B deviated strongly from neutral expectations and positive selection was detected at 20 sites in the G glycoprotein, F fusion protein, and M2-2 regulatory protein. Phylogeographic reconstruction revealed a sharp decline in international viral spread during the pandemic, followed by increasing persistence. Europe consistently served as the predominant global source, followed by Western Pacific and North America. Air-travel volume was the strongest predictor of dissemination (log coefficient >0.68 for both subtypes). Post-pandemic RSV resurgence represented fundamental epidemiological restructuring shaped by a population bottleneck, positive selection and major impact of air-travel. These findings underscore the need for robust genomic surveillance to track the global circulation of lineages, and to monitor effectiveness of pharmaceutical interventions given the emergence of new genotypes.

Related

  1. Spatiotemporal evolution and spatial heterogeneity of driving factors of gonorrhea incidence in Mainland China before and after the COVID-19 pandemic
    Huixian Zhou, Ling Jia
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  2. Global public perceptions of participation in pandemic and non-pandemic trials in the intensive care unit: a cross-sectional survey across 13 countries
    Leanne M. C. Hays, Alex C. Sherry, Attia Fatima +42
    TrialsPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  3. Chronic exposure to Salton Sea aerosols elicits pulmonary inflammation and shifts in murine lung and fecal microbiome diversity
    Talyssa M. Topacio, Mia R. Maltz, David D. Lo +12
    Scientific ReportsPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossref
  4. Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in Adolescents
    Marco Solmi, Trevor Thompson, Samuele Cortese +211
    Journal of the American Academy of Child and Adolescent PsychiatryPeer-reviewedCC BYGeneral biologyPsychiatry & mental healthHAL
  5. Zoonotic viral spillover: from reservoir ecology and viral evolution to pandemic prevention.
    Maryam Mashhadi Abolghasem Shirazi, Ochilova Dilorom, Shamuratova Gulnora Baxtiyorovna +1
    Virus researchPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
BibTeX
@misc{gustanibuss2026pandemicdriven,
  title = {{Pandemic-Driven Shifts in RSV Diversity, Evolution, and Global Spread}},
  author = {E. Gustani-Buss and D. M. Weinberger and N. D. Grubaugh and V. Colizza and Y. Shao and M. Suchard and A. Evers and N. I. Mazur and J. G. Wildenbeest and R. J. Lebbink and H. J. A. A. v. Zoggel and L. Bont and P. Lemey},
  howpublished = {medRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.02.26367099},
  url = {https://www.medrxiv.org/content/10.64898/2026.11.02.26367099v1},
  note = {CC BY-ND},
}
RIS
TY  - UNPB
TI  - Pandemic-Driven Shifts in RSV Diversity, Evolution, and Global Spread
AU  - E. Gustani-Buss
AU  - D. M. Weinberger
AU  - N. D. Grubaugh
AU  - V. Colizza
AU  - Y. Shao
AU  - M. Suchard
AU  - A. Evers
AU  - N. I. Mazur
AU  - J. G. Wildenbeest
AU  - R. J. Lebbink
AU  - H. J. A. A. v. Zoggel
AU  - L. Bont
AU  - P. Lemey
PY  - 2026
DA  - 2026/11/02
PB  - medRxiv
DO  - 10.64898/2026.11.02.26367099
UR  - https://www.medrxiv.org/content/10.64898/2026.11.02.26367099v1
AB  - The COVID-19 pandemic dramatically disrupted the seasonal circulation of RSV, with subsequent heterogeneous global resurgence. We aimed to characterize how pandemic-era disruptions restructured global RSV transmission dynamics, evolutionary patterns, and drivers of reemergence. We show that RSV-A and RSV-B genetic diversity underwent profound pandemic-associated suppression followed by heterogeneous resurgence. The post-pandemic period was characterized by pronounced changes in diversity, with the emergence of novel RSV-A genotypes (A.D.3 and A.D.5.2) and the expansion of the RSV-B, B.D.E.1 genotype. The recovery of RSV-B deviated strongly from neutral expectations and positive selection was detected at 20 sites in the G glycoprotein, F fusion protein, and M2-2 regulatory protein. Phylogeographic reconstruction revealed a sharp decline in international viral spread during the pandemic, followed by increasing persistence. Europe consistently served as the predominant global source, followed by Western Pacific and North America. Air-travel volume was the strongest predictor of dissemination (log coefficient >0.68 for both subtypes). Post-pandemic RSV resurgence represented fundamental epidemiological restructuring shaped by a population bottleneck, positive selection and major impact of air-travel. These findings underscore the need for robust genomic surveillance to track the global circulation of lineages, and to monitor effectiveness of pharmaceutical interventions given the emergence of new genotypes.
ER  -